Logo image of UBI.PA

UBISOFT ENTERTAINMENT (UBI.PA) Stock Fundamental Analysis

EPA:UBI - Euronext Paris - Matif - FR0000054470 - Common Stock - Currency: EUR

9.47  -0.02 (-0.25%)

Fundamental Rating

4

UBI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 47 industry peers in the Entertainment industry. UBI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. UBI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

UBI had negative earnings in the past year.
UBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: UBI reported negative net income in multiple years.
UBI had a positive operating cash flow in each of the past 5 years.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

UBI's Return On Assets of -1.18% is in line compared to the rest of the industry. UBI outperforms 48.94% of its industry peers.
Looking at the Return On Equity, with a value of -3.22%, UBI is in line with its industry, outperforming 53.19% of the companies in the same industry.
UBI has a Return On Invested Capital of 0.81%. This is comparable to the rest of the industry: UBI outperforms 53.19% of its industry peers.
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROIC 0.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

UBI's Operating Margin of 2.46% is in line compared to the rest of the industry. UBI outperforms 55.32% of its industry peers.
With an excellent Gross Margin value of 90.35%, UBI belongs to the best of the industry, outperforming 80.85% of the companies in the same industry.
In the last couple of years the Gross Margin of UBI has remained more or less at the same level.
Industry RankSector Rank
OM 2.46%
PM (TTM) N/A
GM 90.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

UBI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
UBI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that UBI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of UBI (1.29) is comparable to the rest of the industry.
The Debt to FCF ratio of UBI is 4.55, which is a neutral value as it means it would take UBI, 4.55 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.55, UBI perfoms like the industry average, outperforming 57.45% of the companies in the same industry.
UBI has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.32, UBI is not doing good in the industry: 65.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Altman-Z 1.29
ROIC/WACC0.15
WACC5.52%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.32 indicates that UBI has no problem at all paying its short term obligations.
UBI has a Current ratio of 2.32. This is amongst the best in the industry. UBI outperforms 87.23% of its industry peers.
UBI has a Quick Ratio of 2.29. This indicates that UBI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.29, UBI belongs to the best of the industry, outperforming 87.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 2.29
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The earnings per share for UBI have decreased strongly by -131.28% in the last year.
Looking at the last year, UBI shows a very negative growth in Revenue. The Revenue has decreased by -17.46% in the last year.
Measured over the past years, UBI shows a small growth in Revenue. The Revenue has been growing by 3.56% on average per year.
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%

3.2 Future

UBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.56% yearly.
The Revenue is expected to grow by 5.18% on average over the next years.
EPS Next Y253.57%
EPS Next 2Y102.74%
EPS Next 3Y64.12%
EPS Next 5Y34.56%
Revenue Next Year10.63%
Revenue Next 2Y7.23%
Revenue Next 3Y5.57%
Revenue Next 5Y5.18%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UBI. In the last year negative earnings were reported.
UBI is valuated reasonably with a Price/Forward Earnings ratio of 11.01.
Based on the Price/Forward Earnings ratio, UBI is valued cheaply inside the industry as 87.23% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.44. UBI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 11.01
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

UBI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UBI is cheaper than 89.36% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UBI indicates a rather cheap valuation: UBI is cheaper than 89.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.44
EV/EBITDA 2.86
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as UBI's earnings are expected to grow with 64.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y102.74%
EPS Next 3Y64.12%

0

5. Dividend

5.1 Amount

UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UBISOFT ENTERTAINMENT

EPA:UBI (7/18/2025, 7:00:00 PM)

9.47

-0.02 (-0.25%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)10-28 2025-10-28
Inst Owners36.11%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.26B
Analysts55.24
Price Target11.78 (24.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.52%
PT rev (3m)-29.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.01
P/S 0.59
P/FCF 2.44
P/OCF 2
P/B 0.74
P/tB N/A
EV/EBITDA 2.86
EPS(TTM)-0.56
EYN/A
EPS(NY)0.86
Fwd EY9.08%
FCF(TTM)3.88
FCFY40.92%
OCF(TTM)4.73
OCFY49.96%
SpS16.11
BVpS12.8
TBVpS-4.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROCE 1.34%
ROIC 0.81%
ROICexc 1.06%
ROICexgc 3.87%
OM 2.46%
PM (TTM) N/A
GM 90.35%
FCFM 24.05%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Debt/EBITDA 2.5
Cap/Depr 13.39%
Cap/Sales 5.31%
Interest Coverage 250
Cash Conversion 69.7%
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 2.29
Altman-Z 1.29
F-Score6
WACC5.52%
ROIC/WACC0.15
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
EPS Next Y253.57%
EPS Next 2Y102.74%
EPS Next 3Y64.12%
EPS Next 5Y34.56%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%
Revenue Next Year10.63%
Revenue Next 2Y7.23%
Revenue Next 3Y5.57%
Revenue Next 5Y5.18%
EBIT growth 1Y116.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1517.96%
EBIT Next 3Y175.9%
EBIT Next 5Y88.12%
FCF growth 1Y27.27%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y37.41%
OCF growth 3Y12.65%
OCF growth 5Y10.94%